LOI, MAURO
 Distribuzione geografica
Continente #
NA - Nord America 5.117
AS - Asia 3.006
EU - Europa 2.831
SA - Sud America 284
AF - Africa 76
Continente sconosciuto - Info sul continente non disponibili 76
OC - Oceania 43
Totale 11.433
Nazione #
US - Stati Uniti d'America 5.006
RU - Federazione Russa 1.239
CN - Cina 891
SG - Singapore 886
IT - Italia 574
HK - Hong Kong 402
KR - Corea 259
VN - Vietnam 229
BR - Brasile 218
IE - Irlanda 211
SE - Svezia 155
FR - Francia 143
DE - Germania 141
PL - Polonia 110
IN - India 88
FI - Finlandia 83
CA - Canada 73
GB - Regno Unito 73
JO - Giordania 64
AU - Australia 43
BD - Bangladesh 32
JP - Giappone 30
ID - Indonesia 27
AR - Argentina 26
ES - Italia 23
IQ - Iraq 17
MX - Messico 17
NG - Nigeria 16
CZ - Repubblica Ceca 13
NL - Olanda 13
ZA - Sudafrica 11
MA - Marocco 10
CI - Costa d'Avorio 9
CO - Colombia 9
EC - Ecuador 9
PK - Pakistan 9
UZ - Uzbekistan 9
PE - Perù 8
TN - Tunisia 8
UA - Ucraina 8
BE - Belgio 7
CL - Cile 7
AE - Emirati Arabi Uniti 6
SA - Arabia Saudita 6
TR - Turchia 6
CH - Svizzera 5
EG - Egitto 5
HU - Ungheria 5
IL - Israele 5
KE - Kenya 5
LT - Lituania 5
PH - Filippine 5
SC - Seychelles 5
TH - Thailandia 5
KZ - Kazakistan 4
RO - Romania 4
VE - Venezuela 4
AZ - Azerbaigian 3
BJ - Benin 3
BY - Bielorussia 3
CR - Costa Rica 3
GR - Grecia 3
HN - Honduras 3
KG - Kirghizistan 3
MY - Malesia 3
PA - Panama 3
AL - Albania 2
AT - Austria 2
BG - Bulgaria 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
GE - Georgia 2
HR - Croazia 2
JM - Giamaica 2
KH - Cambogia 2
LB - Libano 2
NP - Nepal 2
UY - Uruguay 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
CG - Congo 1
DM - Dominica 1
GL - Groenlandia 1
GT - Guatemala 1
KW - Kuwait 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LV - Lettonia 1
OM - Oman 1
PS - Palestinian Territory 1
PY - Paraguay 1
QA - Qatar 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
Totale 11.354
Città #
Santa Clara 985
Ashburn 726
Singapore 659
Hong Kong 348
Fairfield 285
Seoul 259
Hefei 251
Chandler 248
San Jose 227
Dublin 211
Seattle 150
Dearborn 141
Woodbridge 141
Cambridge 130
Houston 123
Beijing 122
Warsaw 104
Wilmington 101
Los Angeles 93
Munich 86
Milan 82
Ho Chi Minh City 80
Florence 70
Council Bluffs 69
New York 67
Buffalo 66
Lauterbourg 57
The Dalles 56
Hanoi 50
Paris 49
Lawrence 47
Moscow 47
Shanghai 45
Altamura 42
Helsinki 40
Princeton 40
Ann Arbor 39
Rome 39
Kent 38
Melbourne 37
Mumbai 35
San Diego 28
Turku 28
Boston 26
London 25
Clifton 24
Tokyo 24
Orem 23
São Paulo 23
Dallas 22
Frankfurt am Main 22
Montreal 21
Medford 19
Guangzhou 18
Chicago 17
Jakarta 17
Naples 17
Brooklyn 16
Stockholm 16
Toronto 16
Atlanta 15
Bengaluru 15
Phoenix 15
Abuja 14
Haiphong 13
Denver 11
Nanjing 11
West Jordan 11
Figino 10
Abidjan 9
Boardman 9
Chennai 9
Tashkent 9
Yubileyny 9
Buenos Aires 8
Falls Church 8
Johannesburg 8
Miano 8
Pune 8
San Francisco 8
Tianjin 8
Baghdad 7
Biên Hòa 7
Brescia 7
Brno 7
Brussels 7
Da Nang 7
Lappeenranta 7
Mexico City 7
Palermo 7
Redondo Beach 7
Salt Lake City 7
Sydney 7
Turin 7
Belo Horizonte 6
Bologna 6
Changsha 6
Dong Ket 6
Elk Grove Village 6
Lima 6
Totale 7.230
Nome #
Use of an alpha lipoic, methylsulfonylmethane and bromelain dietary supplement (Opera®) for chemotherapy-induced peripheral neuropathy management, a prospective study 403
Efficacy and tolerability of cyberknife stereotactic robotic radiotherapy for primary or secondary orbital lesions: A single-center retrospective experience 283
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 272
PO-0643: Scalp-sparing radiotherapy to minimize alopecia in patients with primary brain cancer 254
A PPAR gamma agonist protects against oral mucositis induced by irradiation in a murine model 248
Stereotactic reirradiation for local failure of brain metastases following previous radiosurgery: Systematic review and meta-analysis 238
A PPAR-gamma agonist protects from radiation-induced intestinal toxicity 237
Patterns of Care and Survival in Elderly Patients With Locally Advanced Soft Tissue Sarcoma 228
Elderly patients affected by head and neck squamous cell carcinoma unfit for standard curative treatment: Is de-intensified, hypofractionated radiotherapy a feasible strategy? 223
Influence of age and subtype in outcome of operable liposarcoma 220
Triple Negative Apocrine Carcinomas as a Distinct Subtype of Triple Negative Breast Cancer: A Case-control Study 218
Enhancement of Soft Tissue Sarcoma Cell Radiosensitivity by Poly(ADP-ribose) Polymerase-1 Inhibitors 218
Peroxisome proliferator activated receptor-gamma stimulation for prevention of 5-fluorouracil-induced oral mucositis in mice 216
Anti PD-L1 DUrvalumab combined with Cetuximab and RadiOtherapy in locally advanced squamous cell carcinoma of the head and neck: A phase I/II study (DUCRO) 213
Gamma Knife Radiosurgery in the management of single and multiple brain metastases 212
Benefit of ablative versus palliative-only radiotherapy in combination with nivolumab in patients affected by metastatic kidney and lung cancer 212
BRCA mutation in breast cancer patients: Prognostic impact and implications on clinical management 201
Prognostic factors in patients with locally advanced head and neck cancer treated with concurrent radiochemotherapy 200
Stereotactic radiotherapy in oligoprogressive and oligorecurrent urothelial cancer patients: A retrospective experience 198
Safety of concurrent adjuvant radiotherapy and chemotherapy for locally advanced soft tissue sarcoma 198
Radiotherapy in the age of cancer immunology: Current concepts and future developments 197
Robotic Stereotactic Retreatment for Biochemical Control in Previously Irradiated Patients Affected by Recurrent Prostate Cancer 196
Cancer stem cells: biology and potential therapeutic applications 192
Assessment of a guideline-based heart substructures delineation in left-sided breast cancer patients undergoing adjuvant radiotherapy: Quality assessment within a randomized phase III trial testing a cardioprotective treatment strategy (SAFE-2014) 191
Safety of concurrent adjuvant radiotherapy and chemotherapy for locally advanced soft tissue sarcoma 187
Artificial Intelligence in radiotherapy: state of the art and future directions 185
Radiosensitizing Effect of Trabectedin on Human Soft Tissue Sarcoma Cells 184
Stereotactic Body Radiotherapy in Oligomestatic/Oligoprogressive Sarcoma: Safety and Effectiveness Beyond Intrinsic Radiosensitivity 182
Incidence of skin toxicity in squamous cell carcinoma of the head and neck treated with radiotherapy and cetuximab: A systematic review 181
Integrating radiation therapy with targeted treatments for breast cancer: From bench to bedside 180
Early biochemical outcomes following PSMA guided approach for bIoCHEmical relapse after prostatectomy-PSICHE trial (NCT05022914): preliminary results 179
Three Months' PSA and Toxicity from a Prospective Trial Investigating STereotactic sAlvage Radiotherapy for Macroscopic Prostate Bed Recurrence after Prostatectomy-STARR (NCT05455736) 174
Clinical outcome of stereotactic body radiotherapy for lung-only oligometastatic head and neck squamous cell carcinoma: Is the deferral of systemic therapy a potential goal? 172
Modulation of tumor-associated macrophage activity with radiation therapy: a systematic review 172
Lobectomy vs Stereotactic Ablative Radiotherapy in NSCLC: a multicentric series in four centers 169
PSMA guided approach for bIoCHEmical relapse after prostatectomy- (PSICHE) trial (NCT05022914). Detection rate and treatment decision after 68Ga-PSMA PET/CT within a prospective study 167
Palliative radiotherapy in older adults with head and neck squamous cell carcinoma: A systematic review 167
Stereotactic Re-irradiation in Recurrent Prostate Cancer after Previous Postoperative or Definitive Radiotherapy: Long-term Results after a Median Follow-up of 4 Years 167
Prospective assessment of AR splice variant and multi-biomarker expression on circulating tumor cells of mCRPC patients undergoing androgen receptor targeted agents: interim analysis of PRIMERA trial (NCT04188275) 166
Study protocol and preliminary results from a mono-centric cohort within a trial testing stereotactic body radiotherapy and abiraterone (ARTO-NCT03449719) 163
Protective Effect of Leuprorelin on Radiation-induced Intestinal Toxicity 161
Management of severe bio-radiation dermatitis induced by radiotherapy and cetuximab in patients with head and neck cancer: emphasizing the role of calcium alginate dressings 160
Prospective assessment of AR splice variant and PSMA detection on circulating tumor cells of mCRPC patients: preliminary analysis of patients enrolled in PRIMERA trial (NCT04188275) 159
Application of Radiomics for the Prediction of Radiation-Induced Toxicity in the IMRT Era: Current State-of-the-Art 157
Ewing family tumors of the appendicular skeleton: a retrospective analysis of prognostic factors 157
Update chemotherapy schedule in the treatment of lung cancer 153
Prognostic impact of nodal relapse in definitive prostate-only irradiation 151
Single-fraction stereotactic body radiotherapy for oligometastatic lymph node relapse in prostate cancer 145
Integrating stereotactic body radiation therapy (SBRT) and systemic treatments in oligoprogressive prostate cancer: new evidence from the literature 145
Impact of stereotactic body radiotherapy vs palliative radiotherapy on oncologic outcomes of patients with metastatic kidney cancer concomitantly treated with immune checkpoint inhibitors: a preliminary, multicentre experience 144
May Different Treatment Volumes and Technical Approaches Have an Impact on Second Malignancies Risk? 141
Durvalumab with cetuximab and radiotherapy for locally advanced squamous cell carcinoma of the head and neck: A phase 1/2 trial 137
Charlson comorbidity index and G8 in older old adult(≥80 years) hepatocellular carcinoma patients treated with stereotactic body radiotherapy 136
Chest wall resection and reconstruction for lung cancer: Surgical techniques and example of integrated multimodality approach 136
Tumor-associated macrophages (TAMs) modulate response to HER2-targeted agents in a humanized mouse model of breast cancer 136
Recent Advances and Current Challenges in Stereotactic Body Radiotherapy for Ultra-Central Lung Tumors 134
Impact of recurrence pattern in patients undergoing a second surgery for recurrent glioblastoma 129
Radiomics in the setting of neoadjuvant radiotherapy: A new approach for tailored treatment 125
Single-fraction radiotherapy (SFRT) for bone metastases: Patient selection and perspectives 124
Killing two birds with a stone: how to maximise benefit from metastasis-directed therapy and modern systemic treatment in oligometastatic hormone sensitive prostate cancer 119
Stereotactic reirradiation with CyberknifeR for locally recurrent prostate cancer, long-term toxicity and clinical outcomes from a monocentric cohort 116
Radiomic Analysis for Human Papillomavirus Assessment in Oropharyngeal Carcinoma: Lessons and Pitfalls for the Next Future 97
Oncological outcomes after tailored PSMA-PET-guided treatment in biochemical relapse after prostatectomy (PSICHE Trial-NCT 05022914) 70
MRI-based radiomic analysis for grading myxoid liposarcoma: a multisequence retrospective study 38
Totale 11.433
Categoria #
all - tutte 35.769
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.769


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022235 0 0 17 26 6 16 9 26 10 9 43 73
2022/2023961 60 175 50 31 85 175 128 74 133 2 29 19
2023/2024584 20 46 63 26 40 84 36 158 8 29 49 25
2024/20253.366 108 320 181 569 894 374 52 191 176 107 152 242
2025/20264.310 483 560 458 377 527 139 528 183 269 282 146 358
2026/2027487 157 308 22 0 0 0 0 0 0 0 0 0
Totale 11.433